Vanda Pharmaceuticals develops and sells prescription medicines for psychiatric, sleep and neurological conditions. It last closed at $3.44 on Nov 20, down 6.13% on the day. The next earnings report for VNDA is expected around Wed, Feb 10, 2027, after the close. For the quarter ended Sep 2026, VNDA reported EPS of -$0.37 on revenue of $69.8M, with revenue up 24.1% from a year ago. Over its last 8 reports the stock moved an average of 9.0% the session after earnings. Over the last 12 months VNDA insiders bought $38K of stock on the open market and sold $2.8M, according to SEC Form 4 filings.
AI Auto Pilots
Is VNDA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VNDA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on VNDAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
VNDA · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 12% below its 20 day and 26% below its 50 day average. It is 72% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the 52 week low at $3.42, and the nearest resistance the Pivot at $3.56.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 7.0%/day
Key levels
$9.9452 week high+189.0%
$5.92200 day average+72.1%
$4.89100 day average+42.2%
$4.3450 day average+26.2%
$4.20Swing high (Nov 11)+22.1%
$3.8720 day average+12.5%
$3.70Pivot R1+7.6%
$3.56Pivot+3.5%
$3.44Last close
$3.4252 week low−0.6%
$3.30Pivot S1−4.1%
Indicators
RSI (14)
31.80
Weak, oversold below 30
Neutral
MACD
-0.18
Below its signal line
Bearish
Stochastic
16.6
Near the bottom of its range
Oversold
ADX (14)
23.6
Weak trend
Williams %R
-96.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-174.6
Oversold below −100, overbought above 100
Oversold
Rate of change
−9.8%
Change over 10 sessions
Bearish
ATR (14)
$0.24
Typical daily range, 7.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 16.4%/day
Key levels
$9.9452 week high+189.0%
$5.92200 day average+72.1%
$4.89100 day average+42.2%
$4.3450 day average+26.2%
$4.20Swing high (Nov 11)+22.1%
$3.8720 day average+12.5%
$3.70Pivot R1+7.6%
$3.56Pivot+3.5%
$3.44Last close
$3.4252 week low−0.6%
$3.30Pivot S1−4.1%
Indicators
RSI (14)
27.27
Oversold below 30
Oversold
MACD
-0.62
Below its signal line
Bearish
Stochastic
11.4
Near the bottom of its range
Oversold
ADX (14)
19.3
No clear trend
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-142.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−32.3%
Change over 10 sessions
Bearish
ATR (14)
$0.57
Typical daily range, 16.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for VNDA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VNDA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow VNDA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for VNDAHow many large options trades hit VNDA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in VNDA in the last 90 days.
From SEC Form 4 filings by VNDA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VNDA is in one of them and how their past VNDA trades turned out.
Vanda Pharmaceuticals is a biopharmaceutical company based in Washington, D.C. It develops and sells prescription medicines for patients with psychiatric, sleep and neurological conditions. Its marketed products include Fanapt for schizophrenia and bipolar I disorder, HETLIOZ for certain sleep-wake disorders, PONVORY for multiple sclerosis, and NEREUS for preventing vomiting caused by motion. The company also has other medicines in development.